P. Bartholomew

The presentation, treatment and outcome of renal cell carcinoma in old age.

A. Rüfer, D. Beaumont, J. Doherty, 1999, Age and ageing.

Comparative pathophysiology, toxicology, and human cancer risk assessment of pharmaceutical-induced hibernoma.

Z. Radi, M. Elwell, W. Vogel, 2013, Toxicology and applied pharmacology.

Chapter 27 – Carcinogenicity Assessment

C. Alden, J. Kreeger, D. Morton, 2013 .

Primary T-cell lymphoma of the brain in a patient at advanced stage of acquired immunodeficiency syndrome.

F. Aydın, P. Bartholomew, D. Vinson, 1998, Archives of pathology & laboratory medicine.

Differential cholinesterase inhibition and muscarinic receptor changes in CD-1 mice made tolerant to malathion.

G. Gianutsos, P. Bartholomew, S. Cohen, 1985, Toxicology and applied pharmacology.

Cellular and functional actions of tofacitinib related to the pathophysiology of hibernoma development

P. Nambiar, A. Papanikolaou, T. Wisialowski, 2017, Regulatory toxicology and pharmacology : RTP.

Injection-site Malignant Fibrous Histiocytomas in a Pegvisomant Carcinogenicity Study in SD Rats

J. Kreeger, D. Morton, P. Bartholomew, 2014, Toxicologic pathology.

Altered colony-forming activities of bone marrow hematopoietic stem cells in mice following short-term in vivo exposure to parathion.

T. Watts, V. Gallicchio, G. Casale, 1987, International journal of cell cloning.

The Intrathecal Infusion of Mesenchymal Stem Cells into Healthy Rabbitsis Safe and Devoid of Neurological or Clinical Complications

Minguell Jj, P. Bartholomew, A. Pereira, 2011 .